Intravenous trimethoprim-sulfamethoxazole alone or combined with tobramycin for infections in cancer patients
- 1 January 1980
- journal article
- research article
- Published by Elsevier in The American Journal of the Medical Sciences
- Vol. 279 (1), 4-13
- https://doi.org/10.1097/00000441-198001000-00001
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Clinical Pharmacology of Intravenously Administered Trimethoprim-SulfamethoxazoleAntimicrobial Agents and Chemotherapy, 1979
- GRAM-NEGATIVE BACILLARY PNEUMONIA IN THE COMPROMISED HOSTMedicine, 1977
- Intravenous Co-Trimoxazole (“Bactrim”) in the Treatment of Acute PyelonephritisChemotherapy, 1977
- CAUSES OF DEATH IN ADULTS WITH ACUTE LEUKEMIAMedicine, 1976
- TREATMENT OF MENINGITIS and SEPTICEMIA IN INFANCY WITH A SULPHAMETHOXAZOLE/TRIMETHOPRIM COMBINATIONActa Paediatrica, 1975
- Therapeutic trials with tobramycinThe American Journal of the Medical Sciences, 1974
- Causes of death in patients with malignant lymphomaThe American Journal of the Medical Sciences, 1974
- Trimethoprim-Sulphamethoxazole Treatment in Staphylococcal Endocarditis and Gram-Negative SepticemiaScandinavian Journal of Infectious Diseases, 1974
- Causes of death in cancer patientsCancer, 1974
- Esch. coli endocarditis successfully treated with oral trimethoprim and sulphamethoxazole.Heart, 1970